199 related articles for article (PubMed ID: 2538826)
1. Human immunodeficiency virus-infected T cells and monocytes are killed by monoclonal human anti-gp41 antibodies coupled to ricin A chain.
Till MA; Zolla-Pazner S; Gorny MK; Patton JS; Uhr JW; Vitetta ES
Proc Natl Acad Sci U S A; 1989 Mar; 86(6):1987-91. PubMed ID: 2538826
[TBL] [Abstract][Full Text] [Related]
2. HIV-infected cells are killed by rCD4-ricin A chain.
Till MA; Ghetie V; Gregory T; Patzer EJ; Porter JP; Uhr JW; Capon DJ; Vitetta ES
Science; 1988 Nov; 242(4882):1166-8. PubMed ID: 2847316
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD4 enhances the efficacy of immunotoxins directed against gp41 of the human immunodeficiency virus.
Pincus SH; McClure J
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):332-6. PubMed ID: 8419938
[TBL] [Abstract][Full Text] [Related]
4. In vitro efficacy of anti-HIV immunotoxins targeted by various antibodies to the envelope protein.
Pincus SH; Cole RL; Hersh EM; Lake D; Masuho Y; Durda PJ; McClure J
J Immunol; 1991 Jun; 146(12):4315-24. PubMed ID: 1710247
[TBL] [Abstract][Full Text] [Related]
5. Immunoconjugates containing ricin A chain and either human anti-gp41 or CD4 kill H9 cells infected with different isolates of HIV, but do not inhibit normal T or B cell function.
Till MA; Ghetie V; May RD; Auerbach PC; Zolla-Pazner S; Gorny MK; Gregory T; Uhr JW; Vitetta ES
J Acquir Immune Defic Syndr (1988); 1990; 3(6):609-14. PubMed ID: 2140127
[TBL] [Abstract][Full Text] [Related]
6. In vitro effects of anti-HIV immunotoxins directed against multiple epitopes on HIV type 1 envelope glycoprotein 160.
Pincus SH; Wehrly K; Cole R; Fang H; Lewis GK; McClure J; Conley AJ; Wahren B; Posner MR; Notkins AL; Tilley SA; Pinter A; Eiden L; Teintze M; Dorward D; Tolstikov VV
AIDS Res Hum Retroviruses; 1996 Jul; 12(11):1041-51. PubMed ID: 8827220
[TBL] [Abstract][Full Text] [Related]
7. Antigenic specificity of antibody-dependent cell-mediated cytotoxicity directed against human immunodeficiency virus in antibody-positive sera.
Koup RA; Sullivan JL; Levine PH; Brewster F; Mahr A; Mazzara G; McKenzie S; Panicali D
J Virol; 1989 Feb; 63(2):584-90. PubMed ID: 2536094
[TBL] [Abstract][Full Text] [Related]
8. Antibody-dependent cellular cytotoxicity is directed against both the gp120 and gp41 envelope proteins of HIV.
Evans LA; Thomson-Honnebier G; Steimer K; Paoletti E; Perkus ME; Hollander H; Levy JA
AIDS; 1989 May; 3(5):273-6. PubMed ID: 2548535
[TBL] [Abstract][Full Text] [Related]
9. Human monoclonal antibody against glycoproteins of human immunodeficiency virus.
Sugano T; Masuho Y; Matsumoto Y; Lake D; Gschwind C; Petersen EA; Hersh EM
Biochem Biophys Res Commun; 1988 Sep; 155(3):1105-12. PubMed ID: 2845963
[TBL] [Abstract][Full Text] [Related]
10. Variants selected by treatment of human immunodeficiency virus-infected cells with an immunotoxin.
Pincus SH; Wehrly K; Tschachler E; Hayes SF; Buller RS; Reitz M
J Exp Med; 1990 Sep; 172(3):745-57. PubMed ID: 1696955
[TBL] [Abstract][Full Text] [Related]
11. Expression and immunogenicity of the extracellular domain of the human immunodeficiency virus type 1 envelope glycoprotein, gp160.
Berman PW; Riddle L; Nakamura G; Haffar OK; Nunes WM; Skehel P; Byrn R; Groopman J; Matthews T; Gregory T
J Virol; 1989 Aug; 63(8):3489-98. PubMed ID: 2545918
[TBL] [Abstract][Full Text] [Related]
12. Recognition of human immunodeficiency virus glycoproteins by natural anti-carbohydrate antibodies in human serum.
Tomiyama T; Lake D; Masuho Y; Hersh EM
Biochem Biophys Res Commun; 1991 May; 177(1):279-85. PubMed ID: 2043114
[TBL] [Abstract][Full Text] [Related]
13. Identification of Human Anti-HIV gp160 Monoclonal Antibodies That Make Effective Immunotoxins.
Pincus SH; Song K; Maresh GA; Hamer DH; Dimitrov DS; Chen W; Zhang MY; Ghetie VF; Chan-Hui PY; Robinson JE; Vitetta ES
J Virol; 2017 Feb; 91(3):. PubMed ID: 27852851
[TBL] [Abstract][Full Text] [Related]
14. Treatment of HIV tissue culture infection with monoclonal antibody-ricin A chain conjugates.
Pincus SH; Wehrly K; Chesebro B
J Immunol; 1989 May; 142(9):3070-5. PubMed ID: 2540236
[TBL] [Abstract][Full Text] [Related]
15. Selective killing of HIV-infected cells by anti-gp120 immunotoxins.
Matsushita S; Koito A; Maeda Y; Hattori T; Takatsuki K
AIDS Res Hum Retroviruses; 1990 Feb; 6(2):193-203. PubMed ID: 2328157
[TBL] [Abstract][Full Text] [Related]
16. Design and In Vivo Characterization of Immunoconjugates Targeting HIV gp160.
Pincus SH; Song K; Maresh GA; Frank A; Worthylake D; Chung HK; Polacino P; Hamer DH; Coyne CP; Rosenblum MG; Marks JW; Chen G; Weiss D; Ghetie V; Vitetta ES; Robinson JE; Hu SL
J Virol; 2017 Feb; 91(3):. PubMed ID: 27795412
[TBL] [Abstract][Full Text] [Related]
17. Potent deglycosylated ricin A chain immunotoxins specifically killing of xenotropic murine retrovirus-infected cells.
Wu M; Masaaki M; Masato N; Masashisa K
Chin Med J (Engl); 1994 May; 107(5):383-5. PubMed ID: 7924583
[No Abstract] [Full Text] [Related]
18. Partial purification of native HIV transmembrane protein gp41: generation of polyclonal and monoclonal antibodies.
Zweig M; Showalter SD; Bladen SV; Gilden RV; Arthur LO; Robey WG; Nara PL; Fischinger PJ
AIDS Res Hum Retroviruses; 1988 Feb; 4(1):51-62. PubMed ID: 3259140
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and processing of human immunodeficiency virus type 1 envelope proteins encoded by a recombinant human adenovirus.
Dewar RL; Natarajan V; Vasudevachari MB; Salzman NP
J Virol; 1989 Jan; 63(1):129-36. PubMed ID: 2535720
[TBL] [Abstract][Full Text] [Related]
20. Expression of membrane-associated and secreted variants of gp160 of human immunodeficiency virus type 1 in vitro and in continuous cell lines.
Berman PW; Nunes WM; Haffar OK
J Virol; 1988 Sep; 62(9):3135-42. PubMed ID: 2841466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
